MedCity News March 10, 2025
Marissa Plescia

Walgreens is selling itself to the private equity firm Sycamore Partners. This comes after the company has faced increased competition from online retailers like Amazon. It remains to be seen, however, if Walgreens will perform better under Sycamore Partners.

Walgreens has long been a staple of American life, with about 8,500 stores across the U.S. and Puerto Rico and reaching some of the most underserved communities.

But after a series of headwinds — including a net loss of $8.6 billion in fiscal year 2024 and the closure of numerous VillageMD clinics — Walgreens Boots Alliance announced late last week that it is selling itself to private equity firm Sycamore Partners for about $10 billion. The total value of the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

Continue Reading

 
Topics: Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Trends
Related Articles:
Pharma Firms Mallinckrodt and Endo Agree to Merge in $6.7B Cash and Stock Deal
Zealand Pharma, Roche Reach Potential $5.3 Billion Deal to Develop Petrelintide for Weight Management
STAT+: Pharmalittle: We’re reading about a Roche deal for an obesity drug, a Gilead HIV drug and more
Roche builds in obesity with $5.3bn Zealand licensing deal
Roche Puts Up $1.65B to Partner With Zealand on ‘Future Foundational Therapy’ for Obesity

Share This Article